Dr. Bazarbashi received his MBBS degree from the King Saud University School of Medicine in Riyadh, Saudi Arabia in 1982. He completed his internal medicine residency and hematology/Medical oncology fellowship at Wayne State University School of Medicine in Detroit, Michigan in 1991. He obtained his American board diploma in internal medicine in 1988 and in medical oncology in 1991 and Hematology in 1992.
Dr. Bazarbashi received his MBBS degree from the King Saud University School of Medicine in Riyadh, Saudi Arabia in 1982. He completed his internal medicine residency and hematology/Medical oncology fellowship at Wayne State University School of Medicine in Detroit, Michigan in 1991. He obtained his American board diploma in internal medicine in 1988 and in medical oncology in 1991 and Hematology in 1992. Dr Bazarbashi then was appointed as a consultant in medical oncology at King Faisal Specialist Hospital and Research Center in 1991 till present. In 1998, He was appointed as head, Section of medical oncology at KFSH&RC till October 2018. In 2016, he was appointed as adjunct professor at Alfaisal University till present, and in 2021 he was appointed as acting director, Oncology center at King Faisal Specialist Hospital and Research Center.
Dr Bazarbashi served as Chairman of the Saudi Cancer Registry from 2001 till 2013. He was a founding member of the Saudi Oncology society and the deputy chairperson from 2009 to 2019. He also served as medical director for the home-health care program at KFSH&RC from 2001 until 2012. Dr. Bazarbashi established the GI and GU multi-disciplinary guideline groups for the Saudi Oncology Society in 2011. He also was invited to serve as a member of the ESMO-GI scientific committee for the annual meeting in 2023. He has published extensively in GI and GU cancer as well as clinical guidelines, with more than 160 abstracts and more than 100 publications in peer-reviewed journals. He is on the editorial board of local and International journals and a reviewer for many local and international journals. He is also on the steering committee of international trials and was a member of the NCCN-MENA colon cancer committee. He currently serves in addition as the chairperson of the Research Ethics committee at KFSH&RC. He is also a member of the scientific committees of the Saudi Cancer Registry, and served on the scientific committee for the Saudi National Cancer Center and many other national committees.
